FlyteHealth Recognized by CMS for Cardio-Kidney-Metabolic Care Ahead of Medicare ACCESS Model

FlyteHealth, a company specializing in precision cardio-kidney-metabolic care, has been recognized by the Centers for Medicare & Medicaid Services (CMS) for its management of electronic Chronic Kidney Disease Management (eCKM) ahead of the upcoming ACCESS Model. The ACCESS Model is a 10-year Medicare payment demonstration set to begin on July 1, 2026, focusing on chronic disease management in areas such as hypertension, dyslipidemia, obesity, central adiposity, and prediabetes. These conditions are key contributors to heart disease, stroke, kidney failure, and diabetes, and FlyteHealth's integrated virtual care model has shown significant clinical and economic benefits in these areas. FlyteHealth's approach is characterized by a dual-engine model that integrates community health workers, medical doctors, nurse practitioners, registered nurses, registered dietitians, and coaches to provide care. This team structure supports strong clinical outcomes across cardio-kidney-metabolic risk factors. The company's model is validated by robust real-world data and is specifically tailored for the Medicare population aged 65 and over. With several years of experience serving Medicare-age adults, FlyteHealth delivers outcomes through a virtual clinical medication intervention combined with intensive behavioral interventions. This operational framework aligns well with the goals of the ACCESS Model, aiming to improve care scalability and effectiveness. FlyteHealth's collaboration with CMS and ACCESS partners is expected to expand its reach to millions of Americans managing chronic cardiometabolic conditions. Founded by leaders in obesity medicine, FlyteHealth utilizes advanced data analytics and artificial intelligence to support cost-effective and scalable care solutions nationwide. The company's platform integrates clinical intelligence with smart technology and decision-support tools that facilitate the translation of complex medical evidence into actionable care plans. FlyteHealth prioritizes measurable outcomes, seeking to improve metabolic health, optimize medication utilization, and reduce overall healthcare costs. This CMS recognition highlights the growing emphasis on innovative, technology-driven chronic disease management models within Medicare. FlyteHealth's inclusion signals the potential for AI-enhanced virtual care platforms to play a significant role in national efforts to address chronic health conditions and optimize care delivery under evolving Medicare payment models.